NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









JDRF

JDRF

New York City, New Yorkbreakthrought1d.org

Overview

JDRF, now known as Breakthrough T1D, is a global non-profit organization that funds type 1 diabetes (T1D) research and makes venture philanthropy investments through its JDRF T1D Fund to accelerate the development of commercial therapies.

Year Founded

1970

Portfolio Companies

39

Investments

JDRF investments
CompanyDateStageLead
COUR PharmaceuticalsJun 2026Series BCo-investor
Ahead TherapeuticsJan 2026GrantLead
PluristyxNov 2025GrantCo-investor
Zag BioOct 2025Series ALead
Kriya TherapeuticsSep 2025Series DCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded1970

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.